INTRODUCTION
It is now well documented that adenosine plays an important regulatory role in the functioning of the central nervous system. It acts as a neuromodulator primarily through inhibition of excitatory neurotransmitter release  Williams, 1984; Snyder, 1985) , producing effects such as sedation, decreased motor activity, inhibition of breathing and anticonvulsant actions (Katims et al., 1983;  Williams, 1984; Eldridge & Millhorn, 1987) . These effects of adenosine appear to be presynaptic, are mediated by adenosine receptors of the A1 subtype (Fredholm & Dunwiddie, 1988) , which are widely distributed throughout the central nervous system (Lewis et al., 1981; Goodman & Snyder, 1982; Daly, 1985; Bruns et al., 1987; Weber et al., 1988) , and involve inhibition of release of acetylcholine, noradrenaline, dopamine or 5-hydroxytryptamine (Fredholm & Dunwiddie, 1988) . The occupied A1 receptor, coupled to G-proteins, may achieve this modulation through inhibition of adenylate cyclase, by inhibition of voltagesensitive Ca2l currents or by an increase in K+ conductance (Proctor & Dunwiddie, 1983; Dolphin et al., 1986; Scott & Dolphin, 1987; Trussel & Jackson, 1985 Fredholm & Dunwiddie, 1988) . Adenosine also plays an important neuroprotective role in that its increased concentration within the central nervous system after metabolic insults such as ischaemia or hypoxia results in vasodilation and increased blood flow (Berne et al., 1974 (Berne et al., , 1987 Winn et al., 1979 Winn et al., , 1981 Mcllwain & Poll, 1986; Van Wylen et al., 1986) . It is envisaged that all these effects are mediated by adenosine that is formed within or released into extracellular spaces. Two routes of extracellular provision of adenosine appear likely. First, adenosine may be produced as the end product of an extracellular purine nucleotide phosphohydrolase pathway. ATP is packaged and released as a co-transmitter with 'classical' neurotransmitters such as acetylcholine (Nagy et al., 1976) , noradrenaline (Geffen & Livett, 1971; Lagercrantz, 1971) or 5-hydroxytryptamine (Da Prada & Pletscher, 1968) . Extracellular hydrolysis of ATP has been described in synaptosomes from peripheral nerves (Zimmermann et al., 1986) or the central nervous system (Nagy, 1986; Richardson et al., 1987) . In this pathway adenosine is formed from extracellular AMP via a membrane-bound 5'-nucleotidase ectoenzyme, and can be removed by uptake into cells by a widely distributed adenosine-transport system (Bender et al., 1980 (Bender et al., , 1981 Bisserbe et al., 1985) . Second, in response to metabolic insults, adenosine may be produced intracellularly after a decrease in the energy charge of the cell and a resulting rise in AMP content (Winn et al., 1979; Fredholm & Hedqvist, 1980; Wojcik & Neff, 1982; Jonzon & Fredholm, 1985; Mcllwain & Poll, 1986) . By analogy with heart muscle (Itoh et al., 1986; Truong et al., 1988; Newby, 1988) , it would seem most likely that this route of adenosine formation should involve an intracellular, soluble, 5'-nucleotidase activity that has been noted in brain (Montero & Fes, 1982; Mallol & Bozal, 1983; Newby et al., 1987) .
The likely importance of the membrane-bound 5'-nucleotidase ectoenzyme in the regulation of purine salvage and of synaptic transmission has been noted by several workers (Phillis et al., 1979; Zimmermann et al., 1979; Heymann et al., 1984; Kreutzberg et al., 1986; Richardson et al., 1987) . Previous work from our and other laboratories has shown that the membrane-bound 5'-nucleotidase activity in adipose tissue and muscle is altered by insulin treatment, diabetes or hypothyroidism (Jamal & Saggerson, 1987; Karnieli et al., 1987; Klip et al., 1988) . In view of known behavioural changes in hypothyroidism (Gold et al., 1981; Reus, 1986) , we have measured membrane-bound 5'-nucleotidase activity in six regions of the rat brain after chemical induction of hypothyroidism. We report some region-specific increases in this activity in synaptosomal fractions.
The reactions catalysed by adenosine deaminase and adenosine kinase represent -the likely major routes of adenosine disposal after its re-uptake or its intracellular formation (Phillips & Newsholme, 1979; Reddington & Pusch, 1983 ). In addition, inhibition of adenosine deaminase influences' brain adenosine content and Vol. 261 potentiates presynaptic effects of adenosine (Muller & Patton, 1979; Zetterstrom et al., 1982) . These two soluble enzyme activities were therefore also measured in the present study. 3900 starches and sugars. The light/dark cycle was 13 h/l h, with light from 06:00 to 19:00 h. Rats to be made hypothroid were selected at age 4 weeks (80-90 g body wt.) and then fed on an iodinedeficient version of the No. 3 Breeding Diet and drank water containing 0.01 00 (w/v) 6-n-propyl-2-thiouracil (Chohan et al., 1984; Saggerson & Carpenter, 1986) . These animals were killed 4 weeks after commencement of this treatment when they weighed 140-170 g. Euthyroid controls fed on a normal diet were also 8 weeks old at time of death, when they weighed 260-280 g.
MATERIALS AND METHODS

Preparation of subcellular fractions
Rats were stunned and then killed by decapitation. Brains were rapidly removed and placed on an ice-cold Petri dish covered with filter paper wetted with 0.32 Msucrose medium containing 10 mM-Tris/HCl buffer (pH 7.4). Six regions of the brain were separated by the dissection procedure outlined by Glowinski & Iverson (1966) . The regions were: cerebellum, medulla oblongata (consisting of medulla oblongata and pons), striatum (consisting of the putamen nucleus, caudate nucleus and globus pallidus nucleus), cortex (corresponding to the telencephalon without the 'striatum' and including white and grey matter of the cerebral cortex), hippocampus and the hypothalamus. Pooled regions from four to six brains, or in some instances whole forebrains, were collected in ice-cold 0.32 M-sucrose medium containing 10 mM-Tris/HCI buffer (pH 7.4), weighed, cut into small pieces and washed with the same medium to remove blood. Homogenates were prepared in a Potter-Elvehjem glass homogenizer with a Teflon pestle (six up-and-down strokes at 500 rev./min with a radial clearance of 0.2 mm). The homogenates were diluted with the ice-cold sucrose medium to give final concentrations of 1 1-15 Qo (w/v), and then fractionated essentially as described by Booth & Clark (1978) with some minor modifications. After an initial centrifugation at 1500 ga. for 3 min, the resulting supernatants were centrifuged at 18000 gav for 10 min to produce crude mitochondrial/synaptosomal pellets. The 18000 g supernatants were re-centrifuged at 105000 g3,1. for 45 min, and the resulting supernatants were stored at -80 'C. The pellets were resuspended in 5 ml of the sucrose medium and then mixed with 25 ml of 120% Ficoll medium [120% (w/w) Ficoll, 0.32 M-sucrose, 10 mM-Tris/HCI buffer (pH 7.4). Portions (5 ml) of these suspensions were pipetted into '14 ml centrifuge tubes, followed by a layer of 2.5 ml of 70 Ficoll medium [7 o Ficoll, 0.32 M-sucrose, 10 mM-Tris/HCI buffer (pH 7.4)] and then a layer of 2.5 ml of 0.32 M-sucrose medium containing 10 mM-Tris/HCI buffer (pH 7.4). After centrifugation at 1 10000 gay, for I h, the myelin and synaptosomal fractions banded at the upper and lower interfaces respectively, with mitochondria pelleting at the bottom of the tubes. The myelin fractions were suspended in 50 mM-Tris/HCl buffer (pH 7.4) and re-centrifuged for 45 min at 105000gav. The resulting washed myelin fractions were finally resuspended in 2-3 ml of the same buffer and stored at -80 'C. The synaptosomal layers were removed from the lower interface and resuspended in 5 mM-Tris/HCI buffer (pH 8.0). After sonication for 30 s, the suspensions were left on ice for 30-45 min to achieve lysis of the synaptosomes, followed by centrifugation for 45 min at 105 000 &v . The resulting synaptic-membrane fractions were resuspended in 2-3 ml of 50 mM-Tris/HCI buffer (pH 7.4) and stored at -80°C.
Analytical methods
Protein contents of subcellular fractions were measured by the method of Lowry et al. (1951) , with bovine albumin as a standard. Lactate dehydrogenase (EC 1.1.1.27) was assayed spectrophotometrically at 25°C (Saggerson, 1974) . Succinate dehydrogenase (EC 1.3.99.1) was assayed spectrophotometrically at 37 'C with 2-(p-iodophenyl)-3-(p-nitrophenyl)-5-phenyltetrazolium chloride as electron acceptor (Prospero, 1974) . 2',3'-Cyclic nucleotide 3'-phosphodiesterase (EC 3.1.4.37) was assayed spectrophotometrically at 25 0C with 2',3'-cyclic NADP+ as substrate (Sogin, 1976) . Acetylcholinesterase (EC 3.1.1.7) was assayed spectrophotometrically at 25°C by using acetylthiocholine as substrate and coupling the reaction to 5,5'-dithiobis-(2-nitrobenzoic acid) (Ellman et al., 1961) . Adenosine deaminase (EC 3.5.4.4) and adenosine kinase (EC 2.7.1.20) were assayed radiochemically at 37°C with [2-3H]adenosine as substrate. The procedures for these assays and the separation of reaction products by t.l.c. were essentially as described by Arch & Newsholme (1978) , with minor modifications (Jamal & Saggerson, 1987) . Both adenosine deaminase and adenosine kinase assays were initiated by addition of 0.01 ml (5-20 ,ug of protein) of brain 105 000 g supernatant. 5'-Nucleotidase (EC 3.1.3.5) was assayed at 37 'C by monitoring the conversion of [2-3H]AMP into [3H]adenosine (Newby et al., 1975 Preliminary experiments (Table 1) , using fractionated homogenates from whole forebrain, established that marker enzymes were distributed in the appropriate fractions in the euthyroid and hypothyroid states. It was noted that hypothyroidism decreased the specific activity of 2',3'-cyclic nucleotide phosphodiesterase in the myelin fraction by 300 (P < 0.01) and also resulted in a striking 680 decrease in the specific activity of lactate dehydrogenase in the soluble fraction (P < 0.001). It is noteworthy that hypothyroidism also results in a major decrease in lactate dehydrogenase activity in whiteadipose-tissue cells (Baht & Saggerson, 1988) . The reasons for these changes are unclear.
5'-Nucleotidase
Membrane-bound 5'-nucleotidase was observed in purified myelin and synaposomal-fraction membranes from all six brain regions tested. Association of a significant production of brain 5'-nucleotidase with myelin has been noted by Cammer et al. (1980) , Heymann et al. (1984) and Casado et al. (1988) . In addition, subcellular-fractionation studies have repeatedly shown the presence of the enzyme on membranes derived from synaptosomal fractions (see, e.g., Phillips & Newsholme, 1979) . However, cytochemical evidence suggests that most of this 'synaptosomal' activity is not derived from neurons, but from glial-cell membranes Kreutzberg et al., , 1986 Heymann et al., 1984) , and in a complement-fixation assay using antiserum to 5'-nucleotidase Richardson (1983) has provided clear evidence that the enzyme is absent from cholinergic neuron terminals.
Although other workers have previously measured 5'-nucleotidase activity in various regions of the rat brain (Sun et al., 1976; Phillips & Newsholme, 1979; Nagata et al., 1984) , we are unaware of any regional study in which activity measurements were made in both purified myelin and synaptosomal-membrane fractions. Table 2 shows that 5'-nucleotidase specific activities in the myelin fraction were relatively uniform between regions, except for a slightly lower activity in the medulla oblongata in the euthyroid state. In euthyroidism, cerebellum, hippocampus, hypothalamus and striatum showed similar activities in the membranes derived from synaptosomes, whereas medulla oblongata showed a relatively high activity (Sun et al., 1976) and cortex showed a relatively low activity (Sun et al., 1976; Phillips & Newsholme, 1979) .
Previous studies using homogenates or membrane preparations from rat or mouse brain have shown a decrease in brain 5'-nucleotidase activity in hypothyroidism (Smith et al., 1980; King et al., 1983; Shanker et al., 1984) . However, these studies were delibertly conducted during the 'critical period' of myei ation, which is highly sensitive to thyroid-hormone status (Balazs et al., 1969; Rosman et al., 1972; Walters & Morell, 1981) . With regard to the present study, it should be stressed that induction of hypothyroidism was not commenced until this process was essentially complete. Table 2 shows that hypothyroidism caused significant increases in 5'-nucleotidase activity in cerebellum (5.5-fold), cortex (4.8-fold), striatum (3.9-fold) and hippocampus (2.3-fold). There were no significant changes in the medulla oblongata or the hypothalamus. By contrast, the 5'-nucleotidase activity in the myelin fraction was unchanged, except for a modest increase in the medulla oblongata. Hypothyroidism therefore brings about a region-specific increase in membrane-bound 5'-nucleotidase activity that is almost entirely confined to structures at, or near to, nerve terminals. Adenosine deaminase and adenosine kinase These activities were assayed in the 105 000 g supernatants. Adenosine deaminase activities in cortex and cerebellum were very similar to those reported by Phillips & Newsholme (1979) . Hypothyroidism had no significant effect on adenosine deaminase activity. Preliminary experiments revealed an anomaly in the assay of Vol. 261 study that the specific activity of adenosine kinase is enriched to a substantially greater extent than that of adenosine deaminase during isolation of high-speed soluble fractions from homogenates of rat brain. It remains to be established whether this is a related phenomenon. Table 2 shows that hypothyroidism decreased adenosine kinase specific activity by approx. 40%0 in cerebellum, hippocampus, hypothalamus and striatum. The cell types responsible for these changes are unknown; nor is it known whether they are expressed at sites where they may readily influence the re-utilization of adenosine.
General considerations
The brain regions showing the largest changes in synaptosomal-membrane 5'-nucleotidase activity were cerebellum, cortex, striatum and, to a lesser extent, hippocampus. A consequent possible increase in extracellular adenosine formation could be accentuated by a decrease in adenosine kinase activity in the cerebellum, striatum and hippocampus as a result of diminished re-utilization of the nucleoside after re-uptake. The striatum has a high content of both Al and A2 adenosine receptors, whereas A1 receptors are abundant in the cerebellum, cortex and hippocampus (Bruns et al., 1987) . Furthermore, it is in the cortex, the striatum and the hippocampus that presynaptic adenosine receptors are known to inhibit neurotransmitter release (Fredholm & Dunwiddie, 1988) . Richardson et al. (1987) have suggested that an increase in the synthesis or expression of postsynaptic 5'-nucleotidase would enhance neuromodulation through an increase in adenosine formation. The present study demonstrates examples of such an increase in activity. It is speculated that this may contribute to the co-existence of depression with thyroid dysfunction (Gold et al., 1981; Reus, 1986) .
